CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Docetaxel

多西他赛 杂质对照品Docetaxel Impurities

EP46 个杂质条目46 impurity entries

本页汇总 多西他赛 的 46 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 46 impurity reference standards of Docetaxel with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 多西他赛(Docetaxel)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesIsolation and characterization of impurities in docetaxel
    Journal of pharmaceutical and biomedical analysis · 2006 · Vasu Dev R et al.  ·  PMID 16330175  ·  DOI
  2. 杂质研究Impurity studiesDifferences between the quality aspects of various generic and branded docetaxel formulations
    Current medical research and opinion · 2021 · Yiding C, Zhongyi H  ·  PMID 33998944  ·  DOI
  3. 杂质研究Impurity studiesPharmaceutical quality of docetaxel generics versus originator drug product: a comparative analysis
    Current medical research and opinion · 2008 · Vial J et al.  ·  PMID 18544188  ·  DOI
  4. 分析方法Analytical MethodsDevelopment of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability
    Asian journal of pharmaceutical sciences · 2017 · Kim DW et al.  ·  PMID 32104319  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of a rapid and sensitive UPLC-MS/MS method for determination of total docetaxel from a lipid microsphere formulation in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2013 · Du P et al.  ·  PMID 23567294  ·  DOI

多西他赛 —— 原料药与杂质对照品Docetaxel — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Docetaxel structure
EP原料药 APIAPI
多西他赛Docetaxel
Docetaxel
CAS No.114977-28-5
Chemical FormulaC43H53NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 1(Docetaxel EP Impurity A) structure
EPA
多西他赛杂质1(多西他赛EP杂质A)Docetaxel Impurity 1(Docetaxel EP Impurity A)
Docetaxel Impurity 1(Docetaxel EP Impurity A)
CAS No.1887057-05-7
Chemical FormulaC41H55NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 2(Docetaxel EP Impurity B) structure
EPB
多西他赛杂质2(多西他赛EP杂质B)Docetaxel Impurity 2(Docetaxel EP Impurity B)
Docetaxel Impurity 2(Docetaxel EP Impurity B)
CAS No.167074-97-7
Chemical FormulaC43H51NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 3(Docetaxel EP Impurity C) structure
EPC
多西他赛杂质3(多西他赛EP杂质C)Docetaxel Impurity 3(Docetaxel EP Impurity C)
Docetaxel Impurity 3(Docetaxel EP Impurity C)
CAS No.153381-68-1
Chemical FormulaC43H53NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 4(Docetaxel EP Impurity D) structure
EPD
多西他赛杂质4(多西他赛EP杂质D)Docetaxel Impurity 4(Docetaxel EP Impurity D)
Docetaxel Impurity 4(Docetaxel EP Impurity D)
CAS No.162784-72-7
Chemical FormulaC43H51NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 7(Docetaxel EP Impurity G) structure
EPG
多西他赛杂质7(多西他赛EP杂质G)Docetaxel Impurity 7(Docetaxel EP Impurity G)
Docetaxel Impurity 7(Docetaxel EP Impurity G)
CAS No.125354-16-7
Chemical FormulaC45H55NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 8 structure
8
多西他赛杂质8Docetaxel Impurity 8
Docetaxel Impurity 8
CAS No.1385028-85-2
Chemical FormulaC43H55NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 9 structure
9
多西他赛杂质9Docetaxel Impurity 9
Docetaxel Impurity 9
CAS No.1095548-05-2
Chemical FormulaC43H55NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 11 structure
11
多西他赛杂质11Docetaxel Impurity 11
Docetaxel Impurity 11
CAS No.1095548-07-4
Chemical FormulaC43H55NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 13(2-Debenzoyl-2-pentenoyl Docetaxel) structure
13
多西他赛杂质13(2-戊烯酰基多西他赛)Docetaxel Impurity 13(2-Debenzoyl-2-pentenoyl Docetaxel)
Docetaxel Impurity 13(2-Debenzoyl-2-pentenoyl Docetaxel)
CAS No.1412898-66-8
Chemical FormulaC41H55NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 15 structure
15
多西他赛杂质15Docetaxel Impurity 15
Docetaxel Impurity 15
CAS No.158810-73-2
Chemical FormulaC46H55Cl2NO16
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 17 structure
17
多西他赛杂质17Docetaxel Impurity 17
Docetaxel Impurity 17
CAS No.145533-34-2
Chemical FormulaC29H36O11
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 18 (13-O-(Triethylsilyl)baccatin IIIl) structure
18
多西他赛杂质18 ( 13-O-(三乙基甲硅烷基)浆果赤霉素IIIl)Docetaxel Impurity 18 (13-O-(Triethylsilyl)baccatin IIIl)
Docetaxel Impurity 18 (13-O-(Triethylsilyl)baccatin IIIl)
CAS No.208406-86-4
Chemical FormulaC37H52O11Si
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 20 structure
20
多西他赛杂质20Docetaxel Impurity 20
Docetaxel Impurity 20
CAS No.172018-16-5
Chemical FormulaC29H36O10
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 21 structure
21
多西他赛杂质21Docetaxel Impurity 21
Docetaxel Impurity 21
CAS No.92950-45-3
Chemical FormulaC29H34O10
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 22 structure
22
多西他赛杂质22Docetaxel Impurity 22
Docetaxel Impurity 22
CAS No.151636-94-1
Chemical FormulaC29H34O10
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 23 structure
23
多西他赛杂质23Docetaxel Impurity 23
Docetaxel Impurity 23
CAS No.158810-72-1
Chemical FormulaC46H55Cl2NO16
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 25 structure
25
多西他赛杂质25Docetaxel Impurity 25
Docetaxel Impurity 25
CAS No.110258-92-9
Chemical FormulaC38H39Cl9O16
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 26 structure
26
多西他赛杂质26Docetaxel Impurity 26
Docetaxel Impurity 26
CAS No.114915-19-4
Chemical FormulaC32H37Cl3O12
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 35 structure
35
多西他赛杂质35Docetaxel Impurity 35
Docetaxel Impurity 35
CAS No.1354900-65-4
Chemical FormulaC51H59NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 36 structure
36
多西他赛杂质36Docetaxel Impurity 36
Docetaxel Impurity 36
CAS No.1095547-98-0
Chemical FormulaC46H55Cl3NO16
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 37 structure
37
多西他赛杂质37Docetaxel Impurity 37
Docetaxel Impurity 37
CAS No.1095547-96-8
Chemical FormulaC46H55Cl3NO16
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 40 structure
40
多西他赛杂质40Docetaxel Impurity 40
Docetaxel Impurity 40
CAS No.133524-69-3
Chemical FormulaC38H45NO12
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 43 structure
43
多西他赛杂质43Docetaxel Impurity 43
Docetaxel Impurity 43
CAS No.154306-81-7
Chemical FormulaC17H17NO2
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 44 structure
44
多西他赛杂质44Docetaxel Impurity 44
Docetaxel Impurity 44
CAS No.147058-27-3
Chemical FormulaC18H21NO3
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 45 structure
45
多西他赛杂质45Docetaxel Impurity 45
Docetaxel Impurity 45
CAS No.154428-10-1
Chemical FormulaC19H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 46 structure
46
多西他赛杂质46Docetaxel Impurity 46
Docetaxel Impurity 46
CAS No.157240-36-3
Chemical FormulaC10H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 47 structure
47
多西他赛杂质47Docetaxel Impurity 47
Docetaxel Impurity 47
CAS No.1217248-58-2
Chemical FormulaC29H34O9
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 48 structure
48
多西他赛杂质48Docetaxel Impurity 48
Docetaxel Impurity 48
CAS No.201856-57-7
Chemical FormulaC18H25NO5
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 49 structure
49
多西他赛杂质49Docetaxel Impurity 49
Docetaxel Impurity 49
CAS No.133577-33-0
Chemical FormulaC43H53NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 51 structure
51
多西他赛杂质51Docetaxel Impurity 51
Docetaxel Impurity 51
CAS No.119-52-8
Chemical FormulaC16H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 53 structure
53
多西他赛杂质53Docetaxel Impurity 53
Docetaxel Impurity 53
CAS No.165173-47-7
Chemical FormulaC29H36O10
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 56 structure
56
多西他赛杂质56Docetaxel Impurity 56
Docetaxel Impurity 56
CAS No.32981-89-8
Chemical FormulaC31H36O11
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 57 structure
57
多西他赛杂质57Docetaxel Impurity 57
Docetaxel Impurity 57
CAS No.518021-32-4
Chemical FormulaC36H44O13
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 60 (10-Deacetyl Paclitaxel Ethyl Analogue) structure
60
多西他赛杂质60 (10-脱乙酰紫杉醇乙基类似物)Docetaxel Impurity 60 (10-Deacetyl Paclitaxel Ethyl Analogue)
Docetaxel Impurity 60 (10-Deacetyl Paclitaxel Ethyl Analogue)
CAS No.173101-59-2
Chemical FormulaC41H49NO13
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 61 (10-Deacetyl Paclitaxel Propyl Analogue) structure
61
多西他赛杂质61 (10-脱乙酰紫杉醇丙基类似物)Docetaxel Impurity 61 (10-Deacetyl Paclitaxel Propyl Analogue)
Docetaxel Impurity 61 (10-Deacetyl Paclitaxel Propyl Analogue)
CAS No.173101-47-8
Chemical FormulaC42H51NO13
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 62 structure
62
多西他赛杂质62Docetaxel Impurity 62
Docetaxel Impurity 62
CAS No.133577-32-9
Chemical FormulaC43H53NO14
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 63 structure
63
多西他赛杂质63Docetaxel Impurity 63
Docetaxel Impurity 63
CAS No.154044-57-2
Chemical FormulaC43H53NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 64 structure
64
多西他赛杂质64Docetaxel Impurity 64
Docetaxel Impurity 64
CAS No.157183-03-4
Chemical FormulaC43H51NO15
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 65 structure
65
多西他赛杂质65Docetaxel Impurity 65
Docetaxel Impurity 65
CAS No.149198-47-0
Chemical FormulaC20H31NO4Si
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 67 structure
67
多西他赛杂质67Docetaxel Impurity 67
Docetaxel Impurity 67
CAS No.161183-22-8
Chemical FormulaC16H19NO5
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 69 structure
69
多西他赛杂质69Docetaxel Impurity 69
Docetaxel Impurity 69
CAS No.143527-70-2
Chemical FormulaC17H23NO5
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 70 structure
70
多西他赛杂质70Docetaxel Impurity 70
Docetaxel Impurity 70
CAS No.223134-87-0
Chemical FormulaC17H23NO5
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 72 structure
72
多西他赛杂质72Docetaxel Impurity 72
Docetaxel Impurity 72
CAS No.114915-14-9
Chemical FormulaC49H55Cl6NO18
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 73 structure
73
多西他赛杂质73Docetaxel Impurity 73
Docetaxel Impurity 73
CAS No.151636-78-1
Chemical FormulaC49H55Cl6NO18
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 74 structure
74
多西他赛杂质74Docetaxel Impurity 74
Docetaxel Impurity 74
CAS No.160651-94-5
Chemical FormulaC49H51Cl6NO19
Purity>95%询价On request
10mg25mg50mg100mg
Docetaxel Impurity 75 structure
75
多西他赛杂质75Docetaxel Impurity 75
Docetaxel Impurity 75
CAS No.160651-89-8
Chemical FormulaC49H55Cl6NO19
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

多西他赛 —— 研究文献与合成路线Docetaxel — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 多西他赛 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Docetaxel. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities
    Malleswara Reddy A, Banda N, Govind Dagdu S, et al. · Scientia pharmaceutica · 2010 · 被引 10cited 10
  2. Isolation and characterization of degradation impurities in docetaxel drug substance and its formulation
    Kumar D, Tomar RS, Deolia SK, et al. · Journal of pharmaceutical and biomedical analysis · 2007 · 被引 27cited 27
  3. Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy
    Qiao H, Chen X, Chen E, et al. · Biomaterials science · 2019 · 被引 36cited 36
  4. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression
    Luo J, Tian J, Chou F, et al. · Cancer letters · 2019 · 被引 18cited 18
  5. Isolation and characterization of impurities in docetaxel
    Vasu Dev R, Moses Babu J, Vyas K, et al. · Journal of pharmaceutical and biomedical analysis · 2006 · 被引 25cited 25
  6. Influence of Polymer Composition on the Controlled Release of Docetaxel: A Comparison of Non-Degradable Polymer Films for Oesophageal Drug-Eluting Stents
    Fouladian P, Afinjuomo F, Arafat M, et al. · Pharmaceutics · 2020 · 被引 12cited 12

合成与制备工艺专利Synthesis & process patents

  1. PREPARATION OF DOCETAXEL
    KADABOINA RAJASEKHAR, NARIYAM SEKHAR MUNASWAMY, MATTI LANKESHWARA RAO, VASAM SRIDHAR, et al. · 公开号 US2011275841US2011275841 · 2011
  2. PREPARATION OF DOCETAXEL
    KADABOINA RAJASEKHAR, NARIYAM SEKHAR MUNASWAMY, MATTI LANKESHWARA RAO, VASAM SRIDHAR, et al. · 公开号 WO2010059916WO2010059916 · 2010
  3. PREPARATION OF DOCETAXEL
    KADABOINA RAJASEKHAR, NARIYAM SEKHAR MUNASWAMY, MATTI LANKESHWARA RAO, VASAM SRIDHAR, et al. · 公开号 EP2358693EP2358693 · 2011
  4. PROCESSES FOR THE PREPARATION OF DOCETAXEL
    VU PHONG, HOLTON ROBERT A · 公开号 KR20080027829KR20080027829 · 2008
  5. PROCESSES FOR THE PREPARATION OF DOCETAXEL
    HOLTON ROBERT A, VU PHONG · 公开号 MX2007015597MX2007015597 · 2008

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

多西他赛 杂质谱研究要点Docetaxel — impurity profiling notes

下面这些是拿到 多西他赛 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Docetaxel, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances